Interdisciplinary Neurosurgery · 2017 · 15 citations · 4 references
MedicineInfectious DiseasesNeurologyNeurodegenerationNeuroinfectious DiseasesCentral Nervous System InfectionsInfection ManagementMultiple SclerosisMultiple Sclerosis PharmacotherapyNeuroinflammationAwarenessCryptococcal Disease ManagementCryptococcal Infection ManagementCryptococcal Infection TreatmentCryptococcal MeningitisFingolimod TherapyMultiple Sclerosis TherapyRelapsing-remitting Multiple Sclerosis Treatment
• Fingolimod is used to treat relapsing-remitting multiple sclerosis (RRMS). • Fingolimod was the 1st orally administered disease modifier approved for RRMS. • We report a case of cryptococcal meningoencephalitis in a patient on fingolimod. • Awareness of the risk of fatal opportunistic infections in patients on fingolimod
4
Jeffrey A. Cohen, Bhupendra Khatri, Frederik Barkhof et al. · Journal of Neurology Neurosurgery & Psychiatry · 2015 · 163 citations · Full text